Keywords: اوتومتر ژنوم سرطان; CECMP; cytoskeletal and extra-cellular matrix protein; DFS; disease-free survival; ECM; extra-cellular matrix; GDC; genome data commons; OS; overall survival; SNP; single nucleotide polymorphism; SNV; single nucleotide variation; SPSS; statistical package
مقالات ISI اوتومتر ژنوم سرطان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اوتومتر ژنوم سرطان; MET; MET proto-oncogene, receptor tyrosine kinase; FISH; fluorescence in situ hybridization; EGFR; epidermal growth factor receptor; PCR; polymerase chain reaction; TCGA; The Cancer Genome Atlas; VEGF; vascular endothelial growth factor; CEP7; chromosome
Keywords: اوتومتر ژنوم سرطان; BP; biological process; CC; cellular component; DAVID; database for annotation, visualization and integrated discovery; DEGs; differentially expressed genes; ES; effect size; GEO; gene expression omnibus; GO; gene ontology; INMEX; integrative meta-analysi
Keywords: اوتومتر ژنوم سرطان; CNAs; copy number aberrations; CRT; chemoradiotherapy; FA; Fanconi anemia; HPV; human papillomavirus; HR; homologous recombination; HRD; Homologous Recombination Deficiency; L/P-SCC; laryngeal and pharyngeal squamous cell carcinoma; LST; Large Scale Trans
Keywords: اوتومتر ژنوم سرطان; AML; acute myeloid leukemia; DFS; disease-free survival; DLBCL; diffuse large B-cell lymphoma; DSPC; 1,2-distearoyl-sn-glycero-3-phosphocholine; DSPE; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine; EPR; enhanced permeation and retention; MB; molecular b
Keywords: اوتومتر ژنوم سرطان; urinary bladder neoplasms; carcinoma; programmed cell death 1 receptor; immunotherapy; APC; antigen-presenting cell; BCG; bacillus Calmette-Guérin; CD; cluster of differentiation; CR; complete response; CTLA-4; cytotoxic T-lymphocyte-associated antigen-4
Keywords: اوتومتر ژنوم سرطان; AYA; adolescent and young adult; CNA; copy number alteration; TCGA; The Cancer Genome Atlas;
Keywords: اوتومتر ژنوم سرطان; Peroxisome; Cancer; Pexophagy; Plasmalogen; Mitochondrion; Metabolism; AA; arachidonic acid; ABCD; ATP-binding cassette (ABC) transporters subfamily D; ACOX; Acyl Coenzyme-A oxidase; AGPS; alkyl-glycerone phosphate synthase; AMACR; α-Methylacyl-CoA racem
Keywords: اوتومتر ژنوم سرطان; GBM; glioblastoma; LGG; lower-grade glioma; CNS; central nervous system; DA; diffused astrocytoma; AA; anaplastic astrocytoma; WHO; World Health Organization; RPPA; reverse phase protein array; TCGA; the cancer genome atlas; IDH; isocitrate dehydrogenase;
Keywords: اوتومتر ژنوم سرطان; WXS; random sequencing of exonic regions selected from the genome; WGS; whole genome sequencing; TCGA; The Cancer Genome Atlas; ICGC; International Cancer Genome Consortium; TNM; TNM Classification of Malignant Tumor; GLMM; generalized linear mixed model;
Keywords: اوتومتر ژنوم سرطان; 5mC; 5- hydroxymethylcytosine; AML; acute myeloid leukemia; BET; bromodomain inhibitors; CCOC; clear cell ovarian cancer; ctDNA; cell-free tumor DNA; ChIP-on-chip; chromatin immunoprecipitation with DNA microarray; CIMP; CpG island methylator phenotype; C
Keywords: اوتومتر ژنوم سرطان; Anticancer activity; Apoptosis; DNA repair; Glioblastoma; Seaweed compounds; Temozolomide; AIC; 5-aminoimidazole-4-carboxamide; Akt; Protein kinase B (PKB); AP site; apurinic/apyrimidinic site; AP-1; activator protein-1; APE-1; AP endonuclease; Bax; Bcl-2
Keywords: اوتومتر ژنوم سرطان; CRC; colorectal cancer; GEO; Gene Expression Omnibus; TCGA; The Cancer Genome Atlas; DEGs; differentially-expressed genes; COAD; colon adenocarcinoma; FDR; false-discovery rate; FC; fold change; DAVID; Database for Annotation, Visualization and Integratio
Keywords: اوتومتر ژنوم سرطان; Papillary thyroid cancer; Whole-exome sequencing; LRRC8D mutation; NDRG1 mutation; The Cancer Genome Atlas;
Keywords: اوتومتر ژنوم سرطان; Ub; ubiquitin; UBLs; ubiquitin-like proteins; DUBs; deubiquitinating enzymes; TCR; T cell receptor; UPS; ubiquitin-proteasome system; IAPs; inhibitors of apoptosis-related proteins; GAPs; GTPase-activating proteins; PI3K; phosphatidylinositol 3-kinase;
Keywords: اوتومتر ژنوم سرطان; MMPs; Matrix metalloproteinases; ECM; extracellular matrix; TSP-2; Thrombospondin-2; FAK; focal adhesion kinase; Akt; protein kinase B; NF-κB; nuclear factor kappa B; Ig; immunoglobulin; DN; dominant negative; shRNA; short hairpin RNA; TCGA; The Cancer G
Keywords: اوتومتر ژنوم سرطان; 5,10-CH2-THF; 5,10-methylene-tetrahydrofolate; CHX; cycloheximide; C; HCC tissues; DAPI; 4,6â²-diamidino-2-phenylindole; DCFH-DA; 2â²,7â²-Dichlorofluorescin diacetate; DMEM; Dulbecco's modified Eagle medium; ECL; enhanced chemiluminescence; EGF; epider
Keywords: اوتومتر ژنوم سرطان; ADAM; a disintegrin and metalloprotease; EGFR; epidermal growth factor receptor; ELANE; elastase, neutrophil expressed; ERK; extracellular signal-regulated kinase; GC; gastric cancer; gp130; glycoprotein 130; IL-11; interleukin-11; JAK; janus kinase; MAPK
Keywords: اوتومتر ژنوم سرطان; MAC; mucinous adenocarcinoma of the salivary gland; CSC; cancer stem cells; PDX; patient-derived xenografts; GEO; gene expression omnibus; TCGA; the cancer genome atlas; Cancer; Salivary mucinous adenocarcinoma; Metastases; Mutations; KRAS; TP53; KDM6A; K
Keywords: اوتومتر ژنوم سرطان; Colorectal Cancer; Cell Lines; Proteomics; Drug Sensitivity; 5-FU; 5-fluorouracil; CMS; consensus molecular subtype; CPTAC; Clinical Proteomic Tumor Analysis Consortium; CRC; colorectal cancer; FDR; false discovery rate; GDSC; Genomics of Drug Sensitivity
Keywords: اوتومتر ژنوم سرطان; Immune Checkpoint; Virtual Microdissection; Molecular Subgroups; Immune Regulation; CCL; chemokine (C-C motif) ligand; CTNNB1; catenin beta 1; CXCL; chemokine (C-X-C motif) ligand; FDR; false discovery rate; FF; fresh frozen; FFPE; formalin-fixed paraffin
Keywords: اوتومتر ژنوم سرطان; Systems biology; Immunotherapy; Cancer genomics; Whole exome sequencing; RNA sequencing; T-cell receptors; Neoantigens; HLA typing; Immuno-predictive score; CTL; Cytotoxic T-lymphocyte; HLA; Human leukocyte antigen; HTS; High-throughput sequencing; IHC; i
Keywords: اوتومتر ژنوم سرطان; Liver Cancer; Aspergillus; Risk Factor; Pathogenesis; AA; aristolochic acid; AFB1; aflatoxin B1; AF-HCC; aflatoxin-associated hepatocellular carcinoma; CBS; cohesin-binding site; CTCF; CCCTC-binding factor; HBV; hepatitis B virus; HCC; hepatocellular carc
Keywords: اوتومتر ژنوم سرطان; ATGs; Autophagy-related genes; HR; Hazard ratios; CI; Confidence intervals; eQTL; Expression quantitative trait loci; meQTL; Methylation quantitative trait loci; TCGA; The Cancer Genome Atlas; GTEx; Genotype-Tissue Expression; RSEM; RNA-Seq by Expectation
Keywords: اوتومتر ژنوم سرطان; BC; breast cancer; ER; oestrogen receptor; IDC; invasive ductal breast cancer; IHC; immunohistochemistry; GG; Genomic Grade; ILC; invasive lobular breast cancer; LOH; loss of heterozygosity; PR; progesterone receptor; RATHER; Rational Therapy for Breast C
Keywords: اوتومتر ژنوم سرطان; SCLC; small cell lung carcinoma; NSCLC; non-small cell lung carcinoma; ADC; adenocarcinoma; SCC; squamous cell carcinoma; EGFR; epidermal growth factor receptor; COSMIC; catalogue of somatic mutations in cancer; WES; whole exome sequencing; TCGA; The Canc
Keywords: اوتومتر ژنوم سرطان; BCL-2; B-cell lymphoma 2; CA-125; cancer antigen-125; CAFs; cancer-associated fibroblasts; CCL17; chemokine (C-C motif) ligand 17; CCL2; chemokine (C-C motif) ligand 2; CXCL12; chemokine (C-X-C motif) ligand 12; DFS; disease-free survival; DNMT; DNA methy
Keywords: اوتومتر ژنوم سرطان; Thyroid cancer; Mouse modeling; Genetics; Pre-clinical models; PTC; Papillary thyroid cancer; MTC; Medullary thyroid cancer; FTC; Follicular thyroid cancer; RAI; radioactive iodine; TCGA; The Cancer Genome Atlas; Tg; Thyroglobulin; TSH; Thyroid stimulatin
Keywords: اوتومتر ژنوم سرطان; Pancreatic cancer; Angiogenesis; Vascular endothelial growth factor (VEGF); ANGPT; angiopoietin; BRAF; serine/threonine-protein kinase B-raf; CAF; cancer associated fibroblast; Cdkn2a; cyclin-dependent kinase inhibitor 2A; CI; confidence interval; CSF1R;
Keywords: اوتومتر ژنوم سرطان; kidney; ureter; carcinoma; biological markers; genomics; MSK-IMPACT; Memorial Sloan Kettering Integrated Mutation Profiling of Actionable Cancer Targets; RNU; radical nephroureterectomy; TCGA; The Cancer Genome Atlas; UTUC; upper tract urothelial carcinom
Keywords: اوتومتر ژنوم سرطان; Translational informatics; Bioinformatics; Clinical research informatics; Biomedical informatics; The Cancer Genome Atlas; TCGA; cBioPortal; Cancer genomics;
Keywords: اوتومتر ژنوم سرطان; AUC; area under the curve; CI; confidence interval; GEO; gene expression omnibus; GO; gene ontology; HR; hazard ratio; IPA; ingenuity pathway analysis; OS; overall survival; OvCa; ovarian cancer; PI; prognosis index; ROC; receiver operating characteristic
Keywords: اوتومتر ژنوم سرطان; Translational informatics; Bioinformatics; Clinical research informatics; Biomedical informatics; The Cancer Genome Atlas; TCGA; cBioPortal; Cancer genomics
Keywords: اوتومتر ژنوم سرطان; DELSA; Data-Enabled Life Alliances; EGP; Estonian Genome Project; EuPA; European Proteomics Association; FDA; Food and Drug Administration; HUPO; Human Proteome Organization; IGS; International Genomics Consortium; LMNs; Low- and Middle-income nations; MI
Keywords: اوتومتر ژنوم سرطان; aCGH; array based comparative genomic hybridization; BCSS; breast cancer specific survival; DFS; disease free survival; EMT; epithelial-mesenchymal transition; EORTC; European Organization for Research and Treatment of Cancer; ER; estrogen receptor; IHC;
Keywords: اوتومتر ژنوم سرطان; Cancer; Genomics; Next-generation sequencing; Report; Variant annotation; CAP; College of American Pathologists; COSMIC; Catalog of Somatic Mutations in Cancer; EMR; electronic medical records; MAF; mutant allele fraction; NCCN; National Comprehensive Can
Keywords: اوتومتر ژنوم سرطان; Targeted cancer therapy; Ovarian cancer stem cells; Personalized medicine; The Cancer Genome Atlas; Ovarian cancer; Breast cancer;
Low DMT1 expression associates with increased oxidative phosphorylation and early recurrence in HCC
Keywords: اوتومتر ژنوم سرطان; Divalent metal-ion transporter-1; Hepatocellular carcinoma; Glycolysis; Oxidative phosphorylation; Mitochondria; The Cancer Genome Atlas;
Loss of MycBP may be associated with the improved survival in 1P co-deletion of lower grade glioma patients
Keywords: اوتومتر ژنوم سرطان; Glioma; Myc; The Cancer Genome Atlas;
KLF15 suppresses cell growth and predicts prognosis in lung adenocarcinoma
Keywords: اوتومتر ژنوم سرطان; NSCLC; non-small cell lung cancer; LAUD; lung adenocarcinoma; KLFs; krüppel-like factors; CCK-8; Cell Counting Kit-8; IHC; immunohistochemistry; TCGA; The Cancer Genome Atlas; KLF15; LUAD; Prognosis; Proliferation; CDKN1A/p21; CDKN2A/p15;
MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancer
Keywords: اوتومتر ژنوم سرطان; Breast cancer; miRNA; miRNA cluster; miRNA co-expression; Microarray; BC; breast cancer; DCIS; ductal carcinoma in-situ; ECM; extracellular matrix; EMT; epithelial to mesenchymal transition; ER; estrogen receptor; GSEA; gene set enrichment analysis; IDC;
Emerging microRNAs in cancer diagnosis, progression, and immune surveillance
Keywords: اوتومتر ژنوم سرطان; Cancer immunity; miR-21; miR-375; oncomiR; Prognostic biomarker; RAS pathway; AKT; serine/threonine-protein kinase; CIP2A; cancerous inhibitor of PP2A; ERK; extracellular-signal-regulated kinase; FFPE; formalin-fixed, paraffin-embedded; HNC; head and neck
Long noncoding RNA CYTOR in cancer: A TCGA data review
Keywords: اوتومتر ژنوم سرطان; Long non-coding RNA; CYTOR; Cancer; Prognosis; Meta-analysis; ceRNA; Competing endogenous RNA; COAD; Colon adenocarcinoma; DFS; Disease-free survival; EMT; Epithelial to mesenchymal transition; ESCA; Oesophageal carcinoma; HR; Hazard ratio; KICH; Kidney C
Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data
Keywords: اوتومتر ژنوم سرطان; ER+; estrogen receptor-positive; ERâ; ER-negative; miRNAs; microRNA; lncRNAs; long non-coding RNAs; C2orf71; chromosome 2 open reading frame 71; ER; estrogen receptor; ncRNA; non-coding RNA; BPs; biological processes; BCAR4; breast cancer anti-estrogen
Mutant cytoskeletal and ECM peptides sensitive to the ST14 protease are associated with a worse outcome for glioblastoma multiforme
Keywords: اوتومتر ژنوم سرطان; Cytoskeleton and extra-cellular matrix; HLA; ST14 protease; Glioblastoma multiforme; Immune cell infiltrates; CECMP; cytoskeletal and extra-cellular matrix coding regions; GBM; Glioblastoma multiforme; HUGO; human genome organization; KM; Kaplan-Meier sur
MicroRNA-876-5p inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by targeting BCL6 corepressor like 1
Keywords: اوتومتر ژنوم سرطان; BCORL1; BCL6 corepressor like 1; HCC; hepatocellular carcinoma; EMT; epithelial-mesenchymal transition; miRNAs; microRNAs; TCGA; The Cancer Genome Atlas; GEO; Gene Expression Omnibus; 3â²-UTR; 3â²-untranslated region; CtBP; C-terminal Binding Protein; C
A gene expression profile associated with perineural invasion identifies a subset of HNSCC at risk of post-surgical recurrence
Keywords: اوتومتر ژنوم سرطان; Head and neck squamous cell carcinoma; Perineural invasion; The Cancer Genome Atlas (TCGA); Gene expression; ALI; angiolymphatic invasion; CPE; consensus purity estimation score; DFS; disease free survival; ECS; extracapsular spread; FDR; false discovery
LINC00657 played oncogenic roles in esophageal squamous cell carcinoma by targeting miR-615-3p and JunB
Keywords: اوتومتر ژنوم سرطان; ESCC; esophageal squamous cell carcinoma; SEER; Surveillance, Epidemiology, and End Results Program; TCGA; the cancer genome atlas; NORAD; Noncoding RNA Activated by DNA Damage; LINCRNA; long intergenic non-coding RNA; ceRNA; competing endogenous RNA; MTT
Overexpressed ACBD3 has prognostic value in human breast cancer and promotes the self-renewal potential of breast cancer cells by activating the Wnt/beta-catenin signaling pathway
Keywords: اوتومتر ژنوم سرطان; ACBD3; Acyl-CoA binding domain containing 3; ER; estrogen receptor; PR; progesterone receptor; Her2; human epidermal growth factor receptor-2; CSC; cancer stem cell; BCSC; breast cancer stem cell; EGFR; epidermal growth factor receptor; ACBP; acyl-CoA-bin
In primary glioblastoma fewer tumor copy number segments of the F13A1 gene are associated with poorer survival
Keywords: اوتومتر ژنوم سرطان; Glioblastoma; Survival; Factor XIII; The Cancer Genome Atlas;